Assessment to barriers of medication adherence among patients with Type 2 Diabetes Mellitus

Umi Athiyah

Makale detayları

Assessment to barriers of medication adherence among patients with Type 2 Diabetes Mellitus

Yazarlar:

Umi Athiyah

Yayıncı:

Marmara University

Ana Başlıklar:

Pharmacology and Pharmaceutical Sciences (Other)

Dergi:

Journal of Research in Pharmacy Vol.29 Issue 3, pp.918-927

Belge Tipi:

Makale

Yayın Tarihi:

4/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001344596

pISSN:

2630-6344

Anahtar kelimeler:

Özet:

 Medication adherence among diabetes mellitus DM patients in Indonesia was predominantly low or nonadherent. Poor adherence raises the risk of developing diabetes-related complications. Specific barriers contribute to the lack of adherence DM patients. The study aimed to identify barriers to medication adherence among DM patients in a primary healthcare center in Indonesia. The cross-sectional study was conducted in 27 primary healthcare centers in Banjarmasin, Indonesia. Patients with DM type 2 were recruited using a purposive sampling technique between February and March 2023. The Diabetes Medication Adherence Barriers Questionnaire DMAB-Q was used to assess barriers to medication adherence. A total of 455 patients with type 2 DM participated in this study. The results of the study found that there were various barriers to medication adherence. In terms of medication-related factors, symptoms that do not immediately improve 65,1, side effects 55,4, and the complexity of the medication regimen 58,9 were reported. Regarding patient-related factors, lack of understanding of treatment goals 65,1, negative perception of medication 53,0, take medicine only when ordered by the pharmacist 32,5, forgetting to take medication 28,4, feeling bored, and feeling obligated to take medication every day 43,3 were identified. As for pharmacistrelated factors, the inability of patients to consult pharmacists promptly when encountering issues with their diabetes medication was prevalent 76,9. Based on this study, it can be concluded that patient-related factors are the most dominant barriers to medication adherence among patients with diabetes mellitus.

 Medication adherence among diabetes mellitus DM patients in Indonesia was predominantly low or nonadherent. Poor adherence raises the risk of developing diabetes-related complications. Specific barriers contribute to the lack of adherence DM patients. The study aimed to identify barriers to medication adherence among DM patients in a primary healthcare center in Indonesia. The cross-sectional study was conducted in 27 primary healthcare centers in Banjarmasin, Indonesia. Patients with DM type 2 were recruited using a purposive sampling technique between February and March 2023. The Diabetes Medication Adherence Barriers Questionnaire DMAB-Q was used to assess barriers to medication adherence. A total of 455 patients with type 2 DM participated in this study. The results of the study found that there were various barriers to medication adherence. In terms of medication-related factors, symptoms that do not immediately improve 65,1, side effects 55,4, and the complexity of the medication regimen 58,9 were reported. Regarding patient-related factors, lack of understanding of treatment goals 65,1, negative perception of medication 53,0, take medicine only when ordered by the pharmacist 32,5, forgetting to take medication 28,4, feeling bored, and feeling obligated to take medication every day 43,3 were identified. As for pharmacistrelated factors, the inability of patients to consult pharmacists promptly when encountering issues with their diabetes medication was prevalent 76,9. Based on this study, it can be concluded that patient-related factors are the most dominant barriers to medication adherence among patients with diabetes mellitus.

 Medication adherence among diabetes mellitus DM patients in Indonesia was predominantly low or nonadherent. Poor adherence raises the risk of developing diabetes-related complications. Specific barriers contribute to the lack of adherence DM patients. The study aimed to identify barriers to medication adherence among DM patients in a primary healthcare center in Indonesia. The cross-sectional study was conducted in 27 primary healthcare centers in Banjarmasin, Indonesia. Patients with DM type 2 were recruited using a purposive sampling technique between February and March 2023. The Diabetes Medication Adherence Barriers Questionnaire DMAB-Q was used to assess barriers to medication adherence. A total of 455 patients with type 2 DM participated in this study. The results of the study found that there were various barriers to medication adherence. In terms of medication-related factors, symptoms that do not immediately improve 65,1, side effects 55,4, and the complexity of the medication regimen 58,9 were reported. Regarding patient-related factors, lack of understanding of treatment goals 65,1, negative perception of medication 53,0, take medicine only when ordered by the pharmacist 32,5, forgetting to take medication 28,4, feeling bored, and feeling obligated to take medication every day 43,3 were identified. As for pharmacistrelated factors, the inability of patients to consult pharmacists promptly when encountering issues with their diabetes medication was prevalent 76,9. Based on this study, it can be concluded that patient-related factors are the most dominant barriers to medication adherence among patients with diabetes mellitus.

 Medication adherence among diabetes mellitus DM patients in Indonesia was predominantly low or nonadherent. Poor adherence raises the risk of developing diabetes-related complications. Specific barriers contribute to the lack of adherence DM patients. The study aimed to identify barriers to medication adherence among DM patients in a primary healthcare center in Indonesia. The cross-sectional study was conducted in 27 primary healthcare centers in Banjarmasin, Indonesia. Patients with DM type 2 were recruited using a purposive sampling technique between February and March 2023. The Diabetes Medication Adherence Barriers Questionnaire DMAB-Q was used to assess barriers to medication adherence. A total of 455 patients with type 2 DM participated in this study. The results of the study found that there were various barriers to medication adherence. In terms of medication-related factors, symptoms that do not immediately improve 65,1, side effects 55,4, and the complexity of the medication regimen 58,9 were reported. Regarding patient-related factors, lack of understanding of treatment goals 65,1, negative perception of medication 53,0, take medicine only when ordered by the pharmacist 32,5, forgetting to take medication 28,4, feeling bored, and feeling obligated to take medication every day 43,3 were identified. As for pharmacistrelated factors, the inability of patients to consult pharmacists promptly when encountering issues with their diabetes medication was prevalent 76,9. Based on this study, it can be concluded that patient-related factors are the most dominant barriers to medication adherence among patients with diabetes mellitus.

Makale detayları

Assessment to barriers of medication adherence among patients with Type 2 Diabetes Mellitus

Yazarlar:

Umi Athiyah

Yayıncı:

Marmara University

Ana Başlıklar:

Pharmacology and Pharmaceutical Sciences (Other)

Dergi:

Journal of Research in Pharmacy Vol.29 Issue 3, pp.918-927

Belge Tipi:

Makale

Yayın Tarihi:

4/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001344596

pISSN:

2630-6344

Type 2 diabetes mellitus

adherence barrier

non-adherence

compliance

primary care

Sayı

Makale detayları

Assessment to barriers of medication adherence among patients with Type 2 Diabetes Mellitus

Yazarlar: Umi Athiyah

Yayıncı: Marmara University

Ana Başlıklar: Pharmacology and Pharmaceutical Sciences (Other)

Dergi: Journal of Research in Pharmacy Vol.29 Issue 3, pp.918-927

Belge Tipi: Makale

Yayın Tarihi: 4/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001344596

pISSN: 2630-6344

Type 2 diabetes mellitus

adherence barrier

non-adherence

compliance

primary care

Sayı

Yazarlar:

Umi Athiyah

Yayıncı:

Marmara University

Ana Başlıklar:

Pharmacology and Pharmaceutical Sciences (Other)

Dergi:

Journal of Research in Pharmacy Vol.29 Issue 3, pp.918-927

Belge Tipi:

Makale

Yayın Tarihi:

4/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001344596

pISSN:

2630-6344